Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective
Authors:
- 1 June 2015
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 41 (6) , 758-765
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Annual financial impact of well‐differentiated thyroid cancer care in the United StatesCancer, 2014
- Attributable costs of differentiated thyroid cancer in the elderly Medicare populationSurgery, 2013
- A Cost-Minimization Analysis Comparing Total Thyroidectomy Alone and Total Thyroidectomy with Prophylactic Central Neck Dissection in Clinically Nodal-Negative Papillary Thyroid CarcinomaAnnals of Surgical Oncology, 2013
- The Increasing Incidence of Thyroid Cancer: The Influence of Access to CareThyroid®, 2013
- The Clinical and Economic Burden of a Sustained Increase in Thyroid Cancer IncidenceCancer Epidemiology, Biomarkers & Prevention, 2013
- Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989Endocrine-Related Cancer, 2013
- International patterns and trends in thyroid cancer incidence, 1973–2002Cancer Causes & Control, 2008
- Evaluation of Trends in the Cost of Initial Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2008
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Temporal Trends for Thyroid Carcinoma in Australia: An Increasing Incidence of Papillary Thyroid Carcinoma (1982–1997)Thyroid®, 2002